Evidence map›Paper›PMID 40034909›Full record

ArticleIJU case reports2025

Salvage robot-assisted radical prostatectomy with pelvic lymph node dissection for radiorecurrent prostate cancer in a patient with a previous history of rectal cancer surgery.

Naoki Imasato, Shugo Yajima, Ryo Andy Ogasawara, Minoru Inoue, Kohei Hirose, Ken Sekiya, Madoka Kataoka, Yasukazu Nakanishi, Hitoshi Masuda

Abstract read
In one paragraph

Article in IJU case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Naoki ImasatoNational Cancer Center Hospital East Chiba Japan.ORCID https://orcid.org/0009-0008-5892-4544
Shugo YajimaNational Cancer Center Hospital East Chiba Japan.
Ryo Andy OgasawaraNational Cancer Center Hospital East Chiba Japan.ORCID https://orcid.org/0009-0008-1177-8789
Minoru InoueNational Cancer Center Hospital East Chiba Japan.
Kohei HiroseNational Cancer Center Hospital East Chiba Japan.ORCID https://orcid.org/0000-0001-6384-7071
Ken SekiyaNational Cancer Center Hospital East Chiba Japan.
Madoka KataokaNational Cancer Center Hospital East Chiba Japan.
Yasukazu NakanishiNational Cancer Center Hospital East Chiba Japan.
Hitoshi MasudaNational Cancer Center Hospital East Chiba Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Severe adhesions render salvage robot-assisted radical prostatectomy challenging in the treatment of patients with prostate cancer who have previously undergone colorectal cancer surgery. Case presentation: A 76-year-old Japanese man who had previously undergone low anterior resection for rectal cancer presented with an elevated prostate-specific antigen level, indicating a recurrence of prostate cancer that had been treated with intensity-modulated radiation and androgen deprivation therapies. During the salvage robot-assisted radical prostatectomy with pelvic lymph node dissection, severe adhesions were noted between the posterior aspect of the prostate and the intestine. The adhesions were successfully dissected under digital rectal examination and transrectal ultrasound guidance. Conclusion: Salvage robot-assisted radical prostatectomy after rectal cancer can be challenging. The use of transrectal ultrasound and digital rectal examination can facilitate the procedure. Screening for prostate cancer prior to colorectal cancer surgery could potentially allow for simultaneous resections.

Indexed as

colorectal cancercolorectal surgeryprostate cancerprostatectomy

Identifiers

PMID40034909
PMCPMC11872196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.